The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
for
Peripheral Blood Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 70+
Code: NCT05436418
Phase 1, Phase 2, Recruiting
Personalized Responses to Dietary Composition Trial 3